U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H18N2O3S
Molecular Weight 354.423
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ST-638

SMILES

CCOC1=C(O)C(CSC2=CC=CC=C2)=CC(\C=C(/C#N)C(N)=O)=C1

InChI

InChIKey=YKLMGKWXBLSKPK-RIYZIHGNSA-N
InChI=1S/C19H18N2O3S/c1-2-24-17-10-13(8-14(11-20)19(21)23)9-15(18(17)22)12-25-16-6-4-3-5-7-16/h3-10,22H,2,12H2,1H3,(H2,21,23)/b14-8+

HIDE SMILES / InChI

Molecular Formula C19H18N2O3S
Molecular Weight 354.423
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/7834843 | https://www.ncbi.nlm.nih.gov/pubmed/18077363 | https://www.ncbi.nlm.nih.gov/pubmed/1479375 | https://www.ncbi.nlm.nih.gov/pubmed/15744060

ST-638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenyl-methylcinnamamide) is a protein tyrosine kinase inhibitor that also inhibits HGF-induced MAP kinase activation in hepatocytes. ST638 has also shown to inhibit PC-PLD (phospholipase D) activity in human neutrophils and suppresses tyrosine phosphorylation induced by tumor necrosis factor-α and phorbol myristate acetate in neutrophils and by angiotensin II in cardiac fibroblasts.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Involvement of Ca2+/calmodulin-dependent protein kinase II in heparin-stimulated release of hepatic lipase activity from rat hepatocytes.
2005-03
Patents

Patents

Sample Use Guides

Rats were treated with ST-638 (30 or 100 mg/kg)
Route of Administration: Intraperitoneal
Rats hepatocytes were isolated by in vitro collagenase perfusion and low speed centrifugation. Cell viability was determined by trypan blue exclusion and ranged from 85 to 95%. The hepatocytes were cultured for 24 h in monolayers in a plastic dish (1x10^5 cells/cm2) in Williams’ medium E containing 10% fetal calf serum, 10 nM insulin, 10 nM dexamethasone and 5 KIU/ml aprotinin under 5%CO2 atmosphere. After removal of the medium by aspiration, monolayers of hepatocytes in the dish were further incubated for 0—90 min in Williams’ medium E containing 2% bovine serum albumin with or without the addition of heparin in the presence of ST-638 (1-5mM). The hepatocytes were harvested and centrifuged at 50xg for 5 min to remove cellular debris. The obtained supernatant served as the preparation for the released HTGL activity. HTGL activity was determined by a method using glycerol tri[1-14C]oleate (1.2mkM; 2.5 kBq/ml) as a substrate
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:34:05 GMT 2025
Edited
by admin
on Mon Mar 31 19:34:05 GMT 2025
Record UNII
6X89Y2007R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
.ALPHA.-CYANO-(3-ETHOXY-4-HYDROXY-5-PHENYLTHIOMETHYL)CINNAMIDE
Preferred Name English
ST-638
Common Name English
Code System Code Type Description
FDA UNII
6X89Y2007R
Created by admin on Mon Mar 31 19:34:05 GMT 2025 , Edited by admin on Mon Mar 31 19:34:05 GMT 2025
PRIMARY
EPA CompTox
DTXSID701147014
Created by admin on Mon Mar 31 19:34:05 GMT 2025 , Edited by admin on Mon Mar 31 19:34:05 GMT 2025
PRIMARY
CAS
107761-24-0
Created by admin on Mon Mar 31 19:34:05 GMT 2025 , Edited by admin on Mon Mar 31 19:34:05 GMT 2025
PRIMARY
PUBCHEM
5941457
Created by admin on Mon Mar 31 19:34:05 GMT 2025 , Edited by admin on Mon Mar 31 19:34:05 GMT 2025
PRIMARY